Early risk stratification in paediatric type 1 diabetes

Acta Ophthalmologica

Volumn 93, Issue A102, 2015, Pages 1-19

  Broe, Rebecca ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; AUTOMATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DENMARK; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EARLY INTERVENTION; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; FRACTAL ANALYSIS; GLYCEMIC CONTROL; GOLD STANDARD; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REMISSION; RETINA ARTERY; RETINA BLOOD VESSEL; RISK ASSESSMENT; RISK MANAGEMENT; VISUAL SYSTEM PARAMETERS; ANALYSIS; CHILD; COMPLICATION; GLUCOSE BLOOD LEVEL; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RETINAL VESSELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84923333451     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12702     Document Type: Article

References (89)

1. Anonymous, (1995): The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44: 968-983.
2. Aiello LP, Cahill MT, &, Wong JS, (2001): Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 132: 760-776.
3. Aldington SJ, Kohner EM, Meuer S, Klein R, &, Sjolie AK, (1995): Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 38: 437-444.
4. Alibrahim E, Donaghue KC, Rogers S, Hing S, Jenkins AJ, Chan A, &, Wong TY, (2006): Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology 113: 1499-1503.
5. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, &, Tamborlane WV, (1986): Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315: 215-219.
6. Anonymous (1985): Early Treatment Diabetic Retinopathy Study (ETDRS): Manual of Operations. Springfield, Va.: U.S. Department of Commerce, National Technical Information Service.
7. Anonymous (1991): Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98: 786-806.
8. Anonymous (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329: 977-986.
9. Anonymous (1998): Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (Clinical research ed.) 317: 703-713.
10. Aspelund T, Thornorisdottir O, Olafsdottir E, et al. (2011): Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 54: 2525-2532.
11. Avakian A, Kalina RE, Sage EH, et al. (2002): Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina. Curr Eye Res 24: 274-280.
12. Azemin MZ, Kumar DK, Wong TY, Kawasaki R, Mitchell P, &, Wang JJ, (2011): Robust methodology for fractal analysis of the retinal vasculature. IEEE Trans Med Imaging 30: 243-250.
13. Azemin MZ, Kumar DK, Wong TY, Wang JJ, Mitchell P, Kawasaki R, &, Wu H, (2012): Age-related rarefaction in the fractal dimension of retinal vessel. Neurobiol Aging 33: 194 e191-194.
14. Bloch CA, Clemons P, &, Sperling MA, (1987): Puberty decreases insulin sensitivity. J Pediatr 110: 481-487.
15. Broe R, Rasmussen ML, Frydkjaer-Olsen U, Olsen BS, Mortensen HB, Peto T, &, Grauslund J, (2013): The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol 2014; 51 (3): 413-20.
16. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, &, Fuller JH, (1998): Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 351: 28-31.
17. Cheung N, Rogers SL, Donaghue KC, Jenkins AJ, Tikellis G, &, Wong TY, (2008): Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 31: 1842-1846.
18. Cheung N, Donaghue KC, Liew G, et al. (2009): Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care 32: 106-110.
19. Cheung CY, Ikram MK, Sabanayagam C, &, Wong TY, (2012a): Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 60: 1094-1103.
20. Cheung CY, Lamoureux E, Ikram MK, et al. (2012b): Retinal vascular geometry in Asian persons with diabetes and retinopathy. J Diabetes Sci Technol 6: 595-605.
21. Chew SK, Xie J, &, Wang JJ, (2012): Retinal arteriolar diameter and the prevalence and incidence of hypertension: a systematic review and meta-analysis of their association. Curr Hypertens Rep 14: 144-151.
22. Daneman D, Wolfson DH, Becker DJ, &, Drash AL, (1981): Factors affecting glycosylated hemoglobin values in children with insulin-dependent diabetes. J Pediatr 99: 847-853.
23. Daxer A, (1993): The fractal geometry of proliferative diabetic retinopathy: implications for the diagnosis and the process of retinal vasculogenesis. Curr Eye Res 12: 1103-1109.
24. Ding J, Cheung CY, Ikram MK, et al. (2012a): Early retinal arteriolar changes and peripheral neuropathy in diabetes. Diabetes Care 35: 1098-1104.
25. Ding J, Ikram MK, Cheung CY, &, Wong TY, (2012b): Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy. Clin Exp Optom 95: 290-296.
26. Giunti S, Barit D, &, Cooper ME, (2006): Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 48: 519-526.
27. Grauslund J, Green A, &, Sjolie AK, (2009a): Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 52: 1829-1835.
28. Grauslund J, Hodgson L, Kawasaki R, Green A, Sjolie AK, &, Wong TY, (2009b): Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia 52: 2213-2217.
29. Grauslund J, Green A, Kawasaki R, Hodgson L, Sjolie AK, &, Wong TY, (2010): Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology 117: 1400-1405.
30. Grunwald JE, Riva CE, Brucker AJ, Sinclair SH, &, Petrig BL, (1984): Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology 91: 1447-1452.
31. Harrison DG, (1997): Endothelial function and oxidant stress. Clin Cardiol 20: II-11-17.
32. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, &, Parving HH, (2003): Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26: 1258-1264.
33. Hubbard LD, Brothers RJ, King WN, et al. (1999): Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106: 2269-2280.
34. Janka HU, Warram JH, Rand LI, &, Krolewski AS, (1989): Risk factors for progression of background retinopathy in long-standing IDDM. Diabetes 38: 460-464.
35. de Jong FJ, Vernooij MW, Ikram MK, et al. (2008): Arteriolar oxygen saturation, cerebral blood flow, and retinal vessel diameters. The Rotterdam Study. Ophthalmology 115: 887-892.
36. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984): The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
37. Klein R, Klein BE, Moss SE, &, Cruickshanks KJ, (1998): The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105: 1801-1815.
38. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, &, Palta M, (2003): Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 110: 2118-2125.
39. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, &, Palta M, (2004): The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 122: 76-83.
40. Klein R, Klein BE, Knudtson MD, Wong TY, &, Tsai MY, (2006a): Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol 124: 87-94.
41. Klein R, Klein BE, Moss SE, Wong TY, &, Sharrett AR, (2006b): Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology 113: 1488-1498.
42. Klein R, Klein BE, Moss SE, &, Wong TY, (2007): Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 114: 1884-1892.
43. Klein R, Knudtson MD, Lee KE, Gangnon R, &, Klein BE, (2008): The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115: 1859-1868.
44. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, &, Klein BE, (2003): Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 27: 143-149.
45. Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, &, Kahn CR, (1986): Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care 9: 443-452.
46. Kyto JP, Harjutsalo V, Forsblom C, Hietala K, Summanen PA, &, Groop PH, (2011): Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 34: 2005-2007.
47. Liew G, Wang JJ, Cheung N, et al. (2008): The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure. Ophthalmology 115: 1951-1956.
48. Lim SW, Cheung N, Wang JJ, Donaghue KC, Liew G, Islam FM, Jenkins AJ, &, Wong TY, (2009): Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care 32: 2081-2083.
49. Lim LS, Cheung CY, Sabanayagam C, Lim SC, Tai ES, Huang L, &, Wong TY, (2013): Structural changes in the retinal microvasculature and renal function. Invest Ophthalmol Vis Sci 54: 2970-2976.
50. Lovestam-Adrian M, Agardh CD, Torffvit O, &, Agardh E, (2001): Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complications 15: 287-294.
51. Macgillivray TJ, Patton N, Doubal FN, Graham C, &, Wardlaw JM, (2007): Fractal analysis of the retinal vascular network in fundus images. Conf Proc IEEE Eng Med Biol Soc 2007: 6456-6459.
52. Mainster MA, (1990): The fractal properties of retinal vessels: embryological and clinical implications. Eye (London, England) 4 (Pt 1): 235-241.
53. Masters BR, (2004): Fractal analysis of the vascular tree in the human retina. Annu Rev Biomed Eng 6: 427-452.
54. Mookiah MR, Acharya UR, Chua CK, Lim CM, Ng EY, &, Laude A, (2013): Computer-aided diagnosis of diabetic retinopathy: a review. Comput Biol Med 43: 2136-2155.
55. Mortensen HB, Hartling SG, &, Petersen KE, (1988): A nation-wide cross-sectional study of glycosylated haemoglobin in Danish children with type 1 diabetes. Diabet Med 5: 871-876.
56. Mortensen HB, Marinelli K, Norgaard K, Main K, Kastrup KW, Ibsen KK, Villumsen J, &, Parving HH, (1990): A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 7: 887-897.
57. Nguyen TT, Kawasaki R, Kreis AJ, Wang JJ, Shaw J, Vilser W, &, Wong TY, (2009a): Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 50: 5609-5613.
58. Nguyen TT, Kawasaki R, Wang JJ, Kreis AJ, Shaw J, Vilser W, &, Wong TY, (2009b): Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 32: 2075-2080.
59. Nordwall M, Bojestig M, Arnqvist HJ, &, Ludvigsson J, (2004): Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linkoping Diabetes Complications Study. Diabetologia 47: 1266-1272.
60. Olsen BS, Johannesen J, Sjolie AK, et al. (1999): Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 16: 79-85.
61. Olsen BS, Sjolie A, Hougaard P, et al. (2000): A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood. J Diabetes Complications 14: 295-300.
62. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, &, Kuller LH, (1990): Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124.
63. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, &, Orchard TJ, (2006): The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55: 1463-1469.
64. Patterson C, Guariguata L, Dahlquist G, Soltesz G, Ogle G, &, Silink M, (2014): Diabetes in the young-a global view and worldwide estimates of numbers of children with type 1 diabetes. Diabetes Res Clin Pract 103: 161-175.
65. Perez-Rovira A, MacGillivray T, Trucco E, et al. (2011): VAMPIRE: vessel assessment and measurement platform for images of the REtina. Conf Proc IEEE Eng Med Biol Soc 2011: 3391-3394.
66. Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, &, Fuller JH, (2001): Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 44: 2203-2209.
67. Reichard P, (1995): Are there any glycemic thresholds for the serious microvascular diabetic complications? J Diabetes Complications 9: 25-30.
68. Reichard P, Nilsson BY, &, Rosenqvist U, (1993): The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309.
69. Relan D, MacGillivray T, Ballerini L, &, Trucco E, (2013): Retinal vessel classification: sorting arteries and veins. Conf Proc IEEE Eng Med Biol Soc 2013: 7396-7399.
70. Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, &, Parving HH, (1998): Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 21: 2007-2015.
71. Roy MS, Klein R, &, Janal MN, (2011): Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus. Arch Ophthalmol 129: 8-15.
72. Sabanayagam C, Tai ES, Lee J, Lim SC, &, Wong TY, (2010): Retinal vessel caliber and peripheral neuropathy in diabetic participants. Microcirculation (New York, NY, 1994) 17: 297-302.
73. Skrivarhaug T, Fosmark DS, Stene LC, Bangstad HJ, Sandvik L, Hanssen KF, &, Joner G, (2006): Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia 49: 2281-2290.
74. Stefansson E, Landers MB III, &, Wolbarsht ML, (1983): Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 14: 209-226.
75. Stosic T, &, Stosic BD, (2006): Multifractal analysis of human retinal vessels. IEEE Trans Med Imaging 25: 1101-1107.
76. Tesfamariam B, Jakubowski JA, &, Cohen RA, (1989): Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am J Physiol 257: H1327-1333.
77. Tsai AS, Wong TY, Lavanya R, Zhang R, Hamzah H, Tai ES, &, Cheung CY, (2011): Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy. Diabetes Res Clin Pract 94: 291-298.
78. Vervoort G, Wetzels JF, Lutterman JA, van Doorn LG, Berden JH, &, Smits P, (1999): Elevated skeletal muscle blood flow in noncomplicated type 1 diabetes mellitus: role of nitric oxide and sympathetic tone. Hypertension 34: 1080-1085.
79. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, &, Keen H, (1982): Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430-1432.
80. Wang PH, Lau J, &, Chalmers TC, (1993): Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341: 1306-1309.
81. Whiting DR, Guariguata L, Weil C, &, Shaw J, (2011): IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311-321.
82. Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, &, Keen H, (1984): Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401-405.
83. Wong TY, &, Mitchell P, (2004): Hypertensive retinopathy. N Engl J Med 351: 2310-2317.
84. Wong TY, &, Mitchell P, (2007): The eye in hypertension. Lancet 369: 425-435.
85. Wong TY, Knudtson MD, Klein R, Klein BE, Meuer SM, &, Hubbard LD, (2004a): Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111: 1183-1190.
86. Wong TY, Shankar A, Klein R, &, Klein BE, (2004b): Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 53: 179-184.
87. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR, &, Shahar E, (2006): Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci 47: 2341-2350.
88. Younes N, Cleary PA, Steffes MW, de Boer IH, Molitch ME, Rutledge BN, Lachin JM, &, Dahms W, (2010): Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clin J Am Soc Nephrol 5: 1235-1242.
89. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, &, Lechi A, (1995): Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 18: 975-982.